Alex Martin, CEO of Abcuro, shares his journey from aspiring actor to biotech leader. With over three decades in biopharma, he discusses his insights on managing the complexities of fundraising amidst market challenges. Alex emphasizes the importance of building mission-driven teams and fostering emotional connections with patients, particularly for Inclusion Body Myositis. He also highlights the need for diverse expertise in leadership and strategies for navigating the transition from private to public company dynamics.